Topic

glp-1

10 articles

FDA sends 25 GLP-1 ad warnings, raising risk for UAE weight-loss clinics

The FDA warning wave targets compounded semaglutide and tirzepatide ads. UAE clinics should audit GLP-1 claims, sourcing and insurer workflows.

3 Oct 2026 · 3 min read

FDA sends 25 GLP-1 ad warnings, raising risk for UAE weight-loss clinics

India fake GLP-1 surge puts UAE clinics on notice as Mounjaro lists at AED 1,734

India’s counterfeit weight-loss drug cases create a UAE compliance risk. Clinics should tighten sourcing, consent and patient screening.

2 Oct 2026 · 3 min read

India fake GLP-1 surge puts UAE clinics on notice as Mounjaro lists at AED 1,734

GLP-1 weight-loss drugs in Dubai: 5 numbers patients should check before starting

A practical UAE guide to GLP-1 weight-loss treatment, including eligibility, likely cost, timelines and regulator checks.

30 Sept 2026 · 3 min read

GLP-1 weight-loss drugs in Dubai: 5 numbers patients should check before starting

AED 1,560 a month for Mounjaro in Dubai: what GLP-1 weight loss actually means

A Dubai-focused guide to GLP-1 weight-loss medication, with prices, eligibility, dosing and safety checks.

28 Aug 2026 · 3 min read

AED 1,560 a month for Mounjaro in Dubai: what GLP-1 weight loss actually means

UAE GLP-1 obesity care now hinges on 10,000-step compliance, Burjeel CMO says

GLP-1 drugs are changing UAE obesity care. Clinics, insurers and patients now need lifestyle tracking, clear eligibility and licensed dietetic support.

28 Aug 2026 · 3 min read

UAE GLP-1 obesity care now hinges on 10,000-step compliance, Burjeel CMO says

Burjeel CMO: GLP-1 obesity care in UAE now needs 10,000-step evidence

A Burjeel obesity adviser says GLP-1 drugs should be tied to diet, sleep and activity plans. Clinics and insurers need documented follow-up.

28 Aug 2026 · 3 min read

Burjeel CMO: GLP-1 obesity care in UAE now needs 10,000-step evidence

10,000 steps enter UAE obesity-drug reimbursement as Burjeel doctor says lifestyle care is required

GLP-1 demand is changing UAE obesity care. Clinics, insurers and patients now need documented lifestyle support, follow-up and coverage checks.

27 Aug 2026 · 3 min read

10,000 steps enter UAE obesity-drug reimbursement as Burjeel doctor says lifestyle care is required

UAE GLP-1 use rises as Burjeel doctor says drugs deliver 50% to 60% of weight-loss plan

GLP-1 demand is changing obesity care in the UAE. Clinics and insurers need documented diet, exercise and follow-up pathways.

27 Aug 2026 · 3 min read

UAE GLP-1 use rises as Burjeel doctor says drugs deliver 50% to 60% of weight-loss plan

Market IntelligenceBreaking

UAE investors chase $39.4 billion GLP-1 opportunity as local healthcare stocks lag

Gulf investors are piling into GLP-1 drug makers Novo Nordisk and Eli Lilly, targeting a $39.4 billion market even as UAE-listed healthcare stocks underperform broader indices by 8-12 percentage points.

7 Apr 2026 · 3 min read

UAE investors chase $39.4 billion GLP-1 opportunity as local healthcare stocks lag

Regulatory & Policy

MOHAP approves first oral GLP-1 pill for UAE's 32% obesity rate, May 2026 launch

MOHAP has approved the UAE's first oral GLP-1 obesity drug, with pharmacies stocking from May 2026. The pill targets a market that grew 41% year-on-year since 2023.

4 Apr 2026 · 3 min read

MOHAP approves first oral GLP-1 pill for UAE's 32% obesity rate, May 2026 launch